Clinical Trial Update: Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating CYT-997 in combination with carboplatin for glioblastoma multiforme has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CYT-997 (CYT-997)

Snippet

Sponsor: Gilead Sciences | Conditions: Glioblastoma Multiforme | Phase 1, Phase 2 | Status: TERMINATED